Literature DB >> 9178641

Expansion of an unusual population of Gr-1+CD3int cells in the lymph nodes and other peripheral organs of mice carrying the lpr gene.

S Honda1, K Takeda, J Narita, T Koya, T Kawamura, Y Kuwano, H Watanabe, M Arakawa, T Abo.   

Abstract

Granulocytes and extrathymic T cells are often activated simultaneously, but they are absolutely separate populations in normal mice. However, some abnormal extrathymic T cells (i.e., CD3int cells) seen in mice carrying the lpr gene were found to express a granulocyte marker, Gr-1. Such mice include MRL-lpr/lpr mice and SCG mice. In parallel with an age-associated increase of IL-2Rbeta(low)CD3int cells which contained double-negative CD4-8- and B220+CD2- cells, Gr-1+CD3int cells increased in number in the lymph nodes and other peripheral organs. In addition to a major population of IL-2Rbeta(low)CD3int cells, there is a small population of IL-2Rbeta(high)CD3int cells which produce normal Fas mRNA and Fas molecule from the lpr gene. It was found that both IL-2Rbeta(low)CD3int and IL-2Rbeta(high)CD3int cell populations contained Gr-1+ cells. IL-2Rbeta(high)CD3int cells tended to contain a higher proportion of Gr-1+ cells than did IL-2Rbeta(low)CD3int cells. More interestingly, Gr-1+CD3int cells expressed a considerable level of mRNA of the mG-CSF receptor, similar to granulocytes. The present study thus yielded further information on an unusual property of abnormally expanding CD3int cells in mice carrying the lpr gene.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178641     DOI: 10.1006/cimm.1997.1104

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  2 in total

1.  Suppressive effect of antiulcer agents on granulocytes--a role for granulocytes in gastric ulcer formation.

Authors:  T Kawamura; C Miyaji; S Toyabe; M Fukuda; H Watanabe; T Abo
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

2.  NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

Authors:  Edward S Morris; Kelli P A MacDonald; Vanessa Rowe; Tatjana Banovic; Rachel D Kuns; Alistair L J Don; Helen M Bofinger; Angela C Burman; Stuart D Olver; Norbert Kienzle; Steven A Porcelli; Daniel G Pellicci; Dale I Godfrey; Mark J Smyth; Geoffrey R Hill
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.